Literature DB >> 1921152

Role of growth hormone in the development of experimental renal scarring.

A M el Nahas1, A H Bassett, G H Cope, J E Le Carpentier.   

Abstract

Recent experimental data has implicated growth hormone in the development of glomerular sclerosis. In this study, we have examined the development and progression of glomerular and tubulointerstitial scarring in Wistar and Dwarf rats, selectively growth hormone-deficient, following subtotal nephrectomy. Wistar rats showed progressive proteinuria, hypertension and renal failure as well as severe renal scarring 120 days after subtotal nephrectomy. In contrast, growth hormone-deficient Dwarf rats had minimal proteinuria, mild renal functional impairment and moderate renal histological scarring. The difference in these functional and structural parameters between the two strains is highly significant, although both experimental groups had comparable food consumption and systemic blood pressure. The significantly smaller glomeruli and limited kidney hypertrophy over 120 days observed in Dwarf rats may account for some of the protection against glomerular sclerosis and tubulointerstitial scarring observed in that strain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921152     DOI: 10.1038/ki.1991.175

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  42 in total

1.  Interference with Gsα-Coupled Receptor Signaling in Renin-Producing Cells Leads to Renal Endothelial Damage.

Authors:  Peter Lachmann; Linda Hickmann; Anne Steglich; Moath Al-Mekhlafi; Michael Gerlach; Niels Jetschin; Steffen Jahn; Brigitte Hamann; Monika Wnuk; Kirsten Madsen; Valentin Djonov; Min Chen; Lee S Weinstein; Bernd Hohenstein; Christian P M Hugo; Vladimir T Todorov
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.

Authors:  Lars P Kihm; Sandra Müller-Krebs; Julia Klein; Gregory Ehrlich; Laura Mertes; Marie-Luise Gross; Antonysunil Adaikalakoteswari; Paul J Thornalley; Hans-Peter Hammes; Peter P Nawroth; Martin Zeier; Vedat Schwenger
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

3.  Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.

Authors:  Kyle Ware; Polina Brodsky; Anjali A Satoskar; Tibor Nadasdy; Gyongyi Nadasdy; Haifeng Wu; Brad H Rovin; Udayan Bhatt; Jon Von Visger; Lee A Hebert; Sergey V Brodsky
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

4.  Unraveling the role of podocyte turnover in glomerular aging and injury.

Authors:  Nicola Wanner; Björn Hartleben; Nadja Herbach; Markus Goedel; Natalie Stickel; Robert Zeiser; Gerd Walz; Marcus J Moeller; Florian Grahammer; Tobias B Huber
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

5.  WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier.

Authors:  Valérie A Schumacher; Ursula Schlötzer-Schrehardt; S Ananth Karumanchi; Xiaofeng Shi; Joseph Zaia; Stefanie Jeruschke; Dongsheng Zhang; Hermann Pavenstädt; Hermann Pavenstaedt; Astrid Drenckhan; Kerstin Amann; Carrie Ng; Sunny Hartwig; Kar-Hui Ng; Jacqueline Ho; Jordan A Kreidberg; Mary Taglienti; Brigitte Royer-Pokora; Xingbin Ai
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

6.  Characterization of the renal phenotype in a mouse model of Marfan syndrome.

Authors:  Andrea Hartner; Timo Eifert; Christian S Haas; Cigdem Tuysuz; Karl F Hilgers; Dieter P Reinhardt; Kerstin Amann
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

7.  Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; Yuki Kaneshiro; Fumiaki Suzuki; Tsutomu Nakagawa; Yuko Tada; Yukako Koura; Akira Nishiyama; Hirokazu Okada; M Nasir Uddin; A H M Nurun Nabi; Yuichi Ishida; Tadashi Inagami; Takao Saruta
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.

Authors:  D P Brooks; B G Short; M J Cyronak; L C Contino; M DiCristo; Y X Wang; R R Ruffolo
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes.

Authors:  Yessoufou Aliou; Min-Chun Liao; Xin-Ping Zhao; Shiao-Ying Chang; Isabelle Chenier; Julie R Ingelfinger; Shao-Ling Zhang
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

10.  Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).

Authors:  Anne Kosfeld; Martin Kreuzer; Christoph Daniel; Frank Brand; Anne-Kathrin Schäfer; Alexandra Chadt; Anna-Carina Weiss; Vera Riehmer; Cécile Jeanpierre; Michael Klintschar; Jan Hinrich Bräsen; Kerstin Amann; Lars Pape; Andreas Kispert; Hadi Al-Hasani; Dieter Haffner; Ruthild G Weber
Journal:  Hum Genet       Date:  2015-11-16       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.